James Goldenring

April 4, 2025

Study details genetic architecture of congenital diarrheal disorders in infants

The findings represent a significant advance toward development of more effective, targeted therapies for congenital diarrhea and enteropathies

By Bill Snyder
Eunyoung Choi, PhD, and James Goldenring, MD, PhD. (photo by Erin O. Smith)
June 4, 2024

Grant funds research for therapies to prevent stomach cancer

The funds will help launch a clinical trial in the U.S. with one of the therapies and compare it with another therapy from an ongoing clinical trial in Japan.

By Tom Wilemon
July 7, 2023

Study reveals new clue to gastric cancer

Researchers at Vanderbilt University Medical Center have uncovered evidence of fibroblast cells’ direct involvement in the development of gastric cancer.

By Bill Snyder
Izumi Kaji, PhD, and James Goldenring, MD, PhD, were among eight researchers from Vanderbilt University Medical Center honored last week by the American Physiological Society.
April 27, 2023

Researchers honored at American Physiology Summit

Three faculty members and five postdoctoral fellows at Vanderbilt University Medical Center received research honors last week from the American Physiological Society during its 2023 American Physiology Summit.

By Bill Snyder
March 23, 2023

Goldenring’s gastrointestinal research contributions lauded

Vanderbilt’s James Goldenring, MD, PhD, has been honored by the American Gastroenterological Association for making significant contributions to understanding gastrointestinal disease.

By Bill Snyder
Eunyoung Choi, PhD, James Goldenring, MD, PhD, and colleagues are studying the development of cancer in the stomach and esophagus.
September 1, 2022

Grant supports research to study gastric cancer origins

Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.

By Tom Wilemon
August 25, 2022

New high-tech biobank safeguards critical specimens

By Bill Snyder
October 14, 2021

New marker for metaplasia

A protein that transports water, called aquaporin 5, is expressed by cells undergoing changes that may increase risk for gastric cancer development, Vanderbilt researchers discovered.
By Bill Snyder
August 5, 2021

Motor protein linked to intestinal cell differentiation

The motor protein MYO5B, a cause of the congenital intestinal disorder microvillus inclusion disease, does more than move cellular cargo, Vanderbilt researchers have discovered.
By Sarah E. Glass
October 15, 2020

Factor involved in stomach injury response identified

Researchers at Vanderbilt University Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori.
By Bill Snyder
January 16, 2020

VUMC study sheds light on gastric cancer development

VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
By Bill Snyder
October 24, 2019

Team set to study undiagnosed congenital diarrhea in infants

Researchers at four institutions, including Vanderbilt, have been awarded a five-year, $9.4 million federal grant to tackle undiagnosed congenital diarrheas caused by a single gene mutation.
By Christina Echegaray
January 23, 2019

Major grant to bolster research on inflammation-related cancers

Cancer Research UK has awarded a 20-million-pound grant (about $25 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.
By Tom Wilemon
1 2 3